Literature DB >> 8435217

Regional therapy of melanoma.

F J Lejeune1, D Liénard, S Leyvraz, R O Mirimanoff.   

Abstract

Little progress has been made in the systemic treatment of melanoma, that is for disseminated stage IV disease. However, the tumour resistance to therapy, especially chemotherapy can be overcome in melanoma by high doses of anticancer agents administered regionally. The purpose of this paper is to illustrate this concept by two modes of regional treatment namely: (1) isolation perfusion of the limbs with high doses of cytokines and chemotherapy under hyperthermia and (2) local treatment of metastatic melanoma. The third part will be devoted to the role of another regional treatment, radiotherapy, where the association with hyperthermy also looks promising.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8435217     DOI: 10.1016/s0959-8049(05)80163-7

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  15 in total

1.  A multi-institutional experience of repeat regional chemotherapy for recurrent melanoma of extremities.

Authors:  Christy Y Chai; Jeremiah L Deneve; Georgia M Beasley; Suroosh S Marzban; Y Ann Chen; Bhupendra Rawal; Stephen R Grobmyer; Steven N Hochwald; Douglas S Tyler; Jonathan S Zager
Journal:  Ann Surg Oncol       Date:  2011-12-06       Impact factor: 5.344

Review 2.  Lymphotoxin signalling in tertiary lymphoid structures and immunotherapy.

Authors:  Haidong Tang; Mingzhao Zhu; Jian Qiao; Yang-Xin Fu
Journal:  Cell Mol Immunol       Date:  2017-04-17       Impact factor: 11.530

Review 3.  Subcutaneous metastases from melanoma: a discussion of clinical experience.

Authors:  Piotr Rutkowski; Marcin Zdzienicki; Katarzyna Kozak
Journal:  Melanoma Manag       Date:  2014-09-05

4.  Preoperative therapy for advanced pelvic malignancy by isolated pelvic perfusion with the balloon-occlusion technique.

Authors:  H J Wanebo; M A Chung; A I Levy; P S Turk; M P Vezeridis; J F Belliveau
Journal:  Ann Surg Oncol       Date:  1996-05       Impact factor: 5.344

Review 5.  Surgery for Metastatic Melanoma: an Evolving Concept.

Authors:  Alessandro A E Testori; Stephanie A Blankenstein; Alexander C J van Akkooi
Journal:  Curr Oncol Rep       Date:  2019-11-06       Impact factor: 5.075

Review 6.  Isolated limb perfusion for extremity soft-tissue sarcomas, in-transit metastases, and other unresectable tumors: credits, debits, and future perspectives.

Authors:  A M Eggermont; T L ten Hagen
Journal:  Curr Oncol Rep       Date:  2001-07       Impact factor: 5.075

7.  One hundred consecutive isolated limb perfusions with TNF-alpha and melphalan in melanoma patients with multiple in-transit metastases.

Authors:  Dirk J Grünhagen; Flavia Brunstein; Wilfried J Graveland; Albertus N van Geel; Johannes H W de Wilt; Alexander M M Eggermont
Journal:  Ann Surg       Date:  2004-12       Impact factor: 12.969

8.  Continuous intraoperative external monitoring of perfusate leak using iodine-131 human serum albumin during isolated perfusion of the liver and limbs.

Authors:  W C Barker; M P Andrich; H R Alexander; D L Fraker
Journal:  Eur J Nucl Med       Date:  1995-11

9.  Hyperthermic isolated limb perfusion for malignant melanoma: response and survival.

Authors:  P J Bryant; G A Balderson; P Mead; W S Egerton
Journal:  World J Surg       Date:  1995 May-Jun       Impact factor: 3.352

Review 10.  Isolated limb perfusion with melphalan and TNF-alpha in the treatment of extremity sarcoma.

Authors:  Cornelis Verhoef; Johannes H W de Wilt; Dirk J Grünhagen; Albertus N van Geel; Timo L M ten Hagen; Alexander M M Eggermont
Journal:  Curr Treat Options Oncol       Date:  2007-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.